Stay updated on LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial

Sign up to get notified when there's something new on the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The history shows the study now indicates no longer looking for participants, signaling that enrollment has closed. The record version has been updated to v3.6.0, replacing the previous v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-12T16:18:16.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The record history now shows a new revision from v3.5.4 to v3.5.5, indicating a page update to the ClinicalTrials.gov interface for this study record. This update reflects an underlying system or display change rather than a content change to the study.
    Difference
    0.1%
    Check dated 2026-06-05T11:30:14.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The Record History now shows Revision: v3.5.4, replacing the prior v3.5.3. This reflects an updated edition of the page's record-keeping view.
    Difference
    0.1%
    Check dated 2026-05-15T05:48:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.2 to v3.5.3, reflecting a software/version release rather than any modification to the trial record.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:39.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision history shows a new latest version: v3.5.2, replacing v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:35:06.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0. The update does not modify the study record data or history.
    Difference
    0.1%
    Check dated 2026-03-19T05:16:19.000Z thumbnail image

Stay in the know with updates to LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page.